Search research articles
Contact Us
Filters
Showing results (241-250 of 272) with videos related to
Page
of 28
Sort By:
Pediatric Blood & Cancer
|
March 4, 2015
Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2
Elizabeth A Raetz, Mitchell S Cairo, Michael J Borowitz, et al.
Journal of Hematology & Oncology
|
September 8, 2016
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
Denise Niewerth, Gertjan J L Kaspers, Gerrit Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
Darren R Hargrave, Eric Bouffet, Uri Tabori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2009
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortium
Tanya M Trippett, Cynthia Herzog, James A Whitlock, et al.
Pediatric Blood & Cancer
|
September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction
Nirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 18, 2010
Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity
M Jonathan Fray, Paul V Fish, Gillian A Allan, et al.
Blood
|
May 4, 2018
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
Oussama Abla, Eric Jacobsen, Jennifer Picarsic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study
Rochelle Bagatell, Lia Gore, Merrill J Egorin, et al.
Journal of Hepatology
|
May 23, 2021
Linkage of resistance-associated substitutions in GT1 sofosbuvir + NS5A inhibitor failures treated with glecaprevir/pibrentasvir
Gary P Wang, Gretja L Schnell, Jens J Kort, et al.
JAMA
|
March 2, 2021
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
Patrick A Brown, Lingyun Ji, Xinxin Xu, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 272) with videos related to
Sort By:
Page
of 28
Pediatric Blood & Cancer
|
March 4, 2015
Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2
Elizabeth A Raetz, Mitchell S Cairo, Michael J Borowitz, et al.
Journal of Hematology & Oncology
|
September 8, 2016
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
Denise Niewerth, Gertjan J L Kaspers, Gerrit Jansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 8, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study
Darren R Hargrave, Eric Bouffet, Uri Tabori, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 23, 2009
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortium
Tanya M Trippett, Cynthia Herzog, James A Whitlock, et al.
Pediatric Blood & Cancer
|
September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction
Nirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 18, 2010
Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity
M Jonathan Fray, Paul V Fish, Gillian A Allan, et al.
Blood
|
May 4, 2018
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
Oussama Abla, Eric Jacobsen, Jennifer Picarsic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study
Rochelle Bagatell, Lia Gore, Merrill J Egorin, et al.
Journal of Hepatology
|
May 23, 2021
Linkage of resistance-associated substitutions in GT1 sofosbuvir + NS5A inhibitor failures treated with glecaprevir/pibrentasvir
Gary P Wang, Gretja L Schnell, Jens J Kort, et al.
JAMA
|
March 2, 2021
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
Patrick A Brown, Lingyun Ji, Xinxin Xu, et al.
Page
of 28